213 related articles for article (PubMed ID: 15875497)
1. [An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].
Enia F; Bella R; Mineo R; Mizio G; Reina G
Ital Heart J Suppl; 2005 Mar; 6(3):121-7. PubMed ID: 15875497
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
3. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
4. [Gram-positive bacterial infections resistant to antibiotic treatment].
Utili R
Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
[TBL] [Abstract][Full Text] [Related]
5. Management of bacterial endocarditis.
Giessel BE; Koenig CJ; Blake RL
Am Fam Physician; 2000 Mar; 61(6):1725-32, 1739. PubMed ID: 10750879
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin resistance in Staphylococcus aureus.
Appelbaum PC; Bozdogan B
Clin Lab Med; 2004 Jun; 24(2):381-402. PubMed ID: 15177846
[TBL] [Abstract][Full Text] [Related]
7. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
12. [Vancomycin-resistant Staphylococcus aureus].
Rodríguez CA; Vesga O
Biomedica; 2005 Dec; 25(4):575-87. PubMed ID: 16433184
[TBL] [Abstract][Full Text] [Related]
13. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
Watanakunakorn C
Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of antibiotic-resistant Gram-positive pathogens.
Lode HM
Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
[TBL] [Abstract][Full Text] [Related]
15. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
Nordmann P; Naas T; Fortineau N; Poirel L
Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
20. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
